CO5690563A2 - Procedimiento microbiologicos para preparar 11 alfa-hidroxi- esteroides 7 alfa-sustituidos - Google Patents

Procedimiento microbiologicos para preparar 11 alfa-hidroxi- esteroides 7 alfa-sustituidos

Info

Publication number
CO5690563A2
CO5690563A2 CO05015699A CO05015699A CO5690563A2 CO 5690563 A2 CO5690563 A2 CO 5690563A2 CO 05015699 A CO05015699 A CO 05015699A CO 05015699 A CO05015699 A CO 05015699A CO 5690563 A2 CO5690563 A2 CO 5690563A2
Authority
CO
Colombia
Prior art keywords
alpha
aspergillus
group
steroids
substitutes
Prior art date
Application number
CO05015699A
Other languages
English (en)
Spanish (es)
Inventor
Ludwig Zorn
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CO5690563A2 publication Critical patent/CO5690563A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CO05015699A 2002-07-24 2005-02-21 Procedimiento microbiologicos para preparar 11 alfa-hidroxi- esteroides 7 alfa-sustituidos CO5690563A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
CO5690563A2 true CO5690563A2 (es) 2006-10-31

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05015699A CO5690563A2 (es) 2002-07-24 2005-02-21 Procedimiento microbiologicos para preparar 11 alfa-hidroxi- esteroides 7 alfa-sustituidos

Country Status (20)

Country Link
EP (1) EP1523568A2 (ja)
JP (1) JP4417838B2 (ja)
KR (1) KR101041328B1 (ja)
CN (1) CN100339486C (ja)
BR (1) BR0313210A (ja)
CA (1) CA2492079C (ja)
CO (1) CO5690563A2 (ja)
CR (1) CR7672A (ja)
EA (2) EA008147B1 (ja)
EC (1) ECSP055630A (ja)
HK (1) HK1081999A1 (ja)
HR (1) HRP20050172A2 (ja)
IL (1) IL166358A0 (ja)
MX (1) MXPA05001024A (ja)
NO (1) NO20050980L (ja)
NZ (2) NZ537871A (ja)
PH (1) PH12005500143B1 (ja)
PL (1) PL373808A1 (ja)
RS (1) RS51855B (ja)
WO (1) WO2004011663A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1947107B1 (en) * 2005-10-27 2012-10-17 SRI International Process for production of steroid compound
CN103834712B (zh) * 2012-11-26 2016-03-30 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因
PL442098A1 (pl) * 2022-08-26 2024-03-04 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania 11α-hydroksy-19-nortestosteronu

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE496261A (ja) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167380A3 (en) 1995-12-11 2004-12-08 G.D. Searle & Co. 11.alpha.-hydroxy-steroid-4,6-dien-3-one compounds and a process for their preparation
PL185223B1 (pl) * 1995-12-12 2003-04-30 Akzo Nobel Nv Mikrobiologiczny sposób in vitro transformacji steroidów w ich 11alfa-hydroksyanalogi
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
EE200200454A (et) 2000-02-15 2003-12-15 Schering Aktiengesellschaft Noretisterooni sisaldav meeste kontratseptiivne preparaat
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
DE50308933D1 (de) * 2002-07-25 2008-02-14 Bayer Schering Pharma Ag Zusammensetzung, enthaltend ein androgenes 11-b-halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung

Also Published As

Publication number Publication date
CN1671858A (zh) 2005-09-21
RS51855B (sr) 2012-02-29
BR0313210A (pt) 2005-06-28
CR7672A (es) 2006-05-29
MXPA05001024A (es) 2005-05-16
EP1523568A2 (de) 2005-04-20
PH12005500143B1 (en) 2011-03-25
CA2492079C (en) 2012-01-10
HK1081999A1 (en) 2006-05-26
NO20050980L (no) 2005-02-23
NZ537871A (en) 2006-10-27
CA2492079A1 (en) 2004-02-05
WO2004011663A9 (de) 2004-05-06
WO2004011663A2 (de) 2004-02-05
WO2004011663A3 (de) 2004-07-15
KR20050026507A (ko) 2005-03-15
EA200500224A1 (ru) 2005-08-25
CN100339486C (zh) 2007-09-26
IL166358A0 (en) 2006-01-16
EA200601030A1 (ru) 2006-10-27
EA008147B1 (ru) 2007-04-27
MX260952B (ja) 2008-10-01
AU2003281677A1 (en) 2004-02-16
EA010572B1 (ru) 2008-10-30
NZ549529A (en) 2008-04-30
RS20050045A (en) 2007-06-04
JP2006503813A (ja) 2006-02-02
JP4417838B2 (ja) 2010-02-17
PL373808A1 (en) 2005-09-19
HRP20050172A2 (en) 2005-04-30
KR101041328B1 (ko) 2011-06-14
ECSP055630A (es) 2005-04-18

Similar Documents

Publication Publication Date Title
CO5690563A2 (es) Procedimiento microbiologicos para preparar 11 alfa-hidroxi- esteroides 7 alfa-sustituidos
NZ526442A (en) Microbial process for the preparation of acetic acid as well as solvent for its extraction from the fermentation broth
DE60312011D1 (de) Schutz von riechstoffen in einer wachskerze unter verwendung eines antioxidans
EA200601005A1 (ru) Способ получения дихлорпропанола из глицерина, причём глицерин получен конверсией животных жиров при изготовлении биодизельного топлива
BRPI0505310A (pt) processo para a preparação de soluções aquosas fluxìveis, altamente concentradas, de betaìnas
ATE163416T1 (de) Gewinnung von tocopherol und sterol
DK1549753T3 (da) Fremgangsmåde til fremstilling af mikrobielt fedt eller olie med nedsat uforsæbeligt stofindhold
NO305208B1 (no) FremgangsmÕte ved fremstilling av polyolpolyestere med lavt triglyceridinnhold
ATE394389T1 (de) Verwendung einer mischung aus fettsäureestern als brennstoff oder lösungsmittel
DE69106884D1 (de) Verfahren zum erhalten hochgradig veresterter polyolfettsäurepolyester mit verringertem gehalt an di-höheralkylketonen und beta-ketoestern.
MX2010010879A (es) Metodo para preparar alquilester de acido graso usando acido graso.
WO2006052567A3 (en) Purification of fluorinated alcohols
MX2007005376A (es) Produccion de biodiesel a partir de pasta de neutralizacion.
BR0112128A (pt) Processo para a preparação de (r)-2-alquil-3-fenil-1-propanóis
MY151001A (en) Fatty acid compositions of methyl ester for esterquats production suitable for fabric softener
AR005043A1 (es) Hidroxilalacion-11 alfa microbiana de esteroides.
MY137101A (en) Process for producing a fatty acid ester
DE69110036D1 (de) Verfahren zur herstellung von fettsäurealkylestern.
ATE361285T1 (de) Verfahren zur herstellung von 3- amidinophenylalanin-derivaten
EP1405841A4 (en) METHOD FOR PRODUCING 2 OXOCARBONIC ACID ESTERS
ATE207868T1 (de) Verfahren zur herstellung von dialkylcarbonaten
DK1149084T3 (da) Fremgangsmåde til fremstilling af L-ascorbinsyre
MXPA01011815A (es) Utilizacion dce emulsiones pit en procesos de fermentacion.
FI20030540A0 (fi) Hydrolyysimenetelmä
CN102286030B (zh) 一种l-来苏糖的制备方法

Legal Events

Date Code Title Description
FG Application granted
FD Application lapsed